Protected: FibriCheck expands its footprint in the Netherlands with four new hospital partnerships
This is a password protected post.
This is a password protected post.
FibriCheck and Smart Meter are now collaborating to bring remote heart health monitoring to U.S. patients. This partnership supports healthcare providers with insights into critical heart rhythm data for improved clinical decision-making. This integration can be scaled into remote patient…
HASSELT - February 21, 2025 - Digital health pioneers Inhealthcare and FibriCheck today announced the expansion of their partnership to bring hospital-grade heart monitoring into patients' homes through NHS virtual ward pathways. Inhealthcare has developed more than 150 clinically designed…
With cardiovascular disease being one of the leading causes of death in the United Kingdom and the current healthcare system being under immense pressure, the NHS rolled out a long term plan to tackle this issue. In this plan, cardiovascular…
Since the beginning of 2022, several Belgian health insurers - including Helan – have started with a reimbursement of up to 20 euros per calendar year for the use of a medical app like FibriCheck. In our partnership with Helan…
The link between the medically certified FibriCheck app and Patients Know Best is now up and running, allowing users of both solutions to seamlessly share and connect their personal health data. This link helps further comprehensive, person-centred assessment and shared…
The Staffordshire and Stoke on Trent Integrated Care System (ICS) - has introduced the use of FibriCheck, enabling patients with palpitations to check their heart rhythm from the comfort of home, without need for a hospital visit or additional equipment.
FibriCheck is thrilled to announce its strategic partnership with Pfizer and AlTibbi, the leading digital health platform in the MENA region, by launching the first of its kind awareness campaign to detect atrial fibrillation in the United Arab Emirates (UAE).
As part of their CW Innovation programme, the Chelsea and Westminster Hospital NHS Foundation Trust and its charity CW+ started a clinical trial exploring the use of FibriCheck to detect atrial fibrillation (AF) in people who recently suffered a stroke.
Atrial Fibrillation (AF) is one of the leading causes of stroke and often goes undiagnosed due to lack of symptoms.1 It is estimated that 300,000 people are living with undiagnosed AF and that over 2,000 lives could be saved every…